Korean J Med.  2010 Feb;78(2):155-162.

Drug therapy of gastroesophageal reflux disease: Good treatment strategies in Korea and recently developed drugs

• Ryu HS
• Choi SC

Abstract

The prevalence of gastroesophageal reflux disease (GERD) in Western countries ranges between 10% and 20%. Although GERD is increasing in Korea, it is difficult to actively conduct studies due to restrictions in insurance regulations and there are practical limitations to prescribe drugs conforming the evidence-based guidelines. As novel drug therapy for GERD, drugs with new mechanisms that would overcome pharmacokinetic limits of proton pump inhibitors are being investigated. In this review, with regards to drug therapy of GERD, we discuss management strategies suitable for domestic circumstances and drugs that are being newly developed.

Keyword

Gastroesophageal reflux disease; Drug therapy

MeSH Terms

Gastroesophageal Reflux
Insurance
Korea
Prevalence
Proton Pump Inhibitors
Social Control, Formal
Proton Pump Inhibitors